PVCT — PROVECTUS PHARMACEUTICAL INCORPORATED
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 3 SEC-registered investment managers reported holding PVCT (PROVECTUS PHARMACEUTICAL INCORPORATED) in their latest 13F filings, with a combined reported value of $8.97K across 129.81K shares. That is +0.0% by share count (+0 shares) versus the previous quarter, while reported value moved +34.3%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of PROVECTUS PHARMACEUTICAL INCORPORATED (PVCT) include HOME FEDERAL BANK OF TENNESSEE, LEE DANNER & BASS INC, Wealth Preservation Advisors, LLC, ranked by reported 13F value among the 7 institutional holders on this page.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 3 | 129.81K | $7.40K | +0.0% |
| Q2 2026 | 3 | 129.81K | $8.97K | +0.0% |
| Q1 2026 | 4 | 182.41K | $9.36K | +0.0% |
| Q4 2025 | 3 | 162.79K | $9.11K | +0.0% |
| Q3 2025 | 5 | 209.41K | $18.64K | +0.3% |
| Q2 2025 | 5 | 208.81K | $15.58K | +0.0% |
| Q1 2025 | 5 | 208.81K | $20.88K | +0.0% |
| Q4 2024 | 4 | 156.81K | $18.82K | +0.0% |
Over the 8 quarters shown, institutional share counts decreased 17% in aggregate (Q4 2024 → Q3 2026).
Top Institutional Holders (Q3 2026) — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 100.00K | $5.70K | 0.00% | Hold | |
| 19.62K | $1.12K | 0.00% | Hold | |
| 10.19K | $582 | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 100.00K | $6.90K | 0.00% | Hold | |
| 19.62K | $1.36K | 0.00% | Hold | |
| 10.19K | $707 | 0.00% | Hold |
Q1 2026 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 100.00K | $5.10K | 0.00% | Hold | |
| 52.60K | $2.68K | 0.00% | Hold | |
| 19.62K | $999 | 0.00% | New | |
| 10.19K | $581 | 0.00% | Hold |
Q4 2025 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 100.00K | $5.60K | 0.00% | Hold | |
| 52.60K | $2.94K | 0.00% | Hold | |
| 10.19K | $570 | 0.00% | Hold |
Q3 2025 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 100.00K | $8.90K | 0.00% | Hold | |
| 52.60K | $4.68K | 0.00% | Add | |
| 26.62K | $2.37K | 0.00% | Hold | |
| 20.00K | $1.78K | 0.00% | Hold | |
| 10.19K | $907 | 0.00% | Hold |
Q2 2025 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 100.00K | $7.50K | 0.00% | Hold | |
| 52.00K | $3.90K | 0.00% | Hold | |
| 26.62K | $1.92K | 0.00% | Hold | |
| 20.00K | $1.50K | 0.00% | Hold | |
| 10.19K | $763 | 0.00% | Hold |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
- Wealth Preservation Advisors, LLC sold 52.60K sh · $2.68K
Fund Position History — shares by quarter (top 7 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HOME FEDERAL BANK OF TENNESSEE | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K |
| Atlas Wealth LLC | 19.62K | 19.62K | 19.62K | — | 26.62K | 26.62K | 26.62K | 26.62K | 26.62K | 26.62K | 26.62K | 26.62K | 26.62K |
| Financial Symmetry Inc | 10.19K | 10.19K | 10.19K | 10.19K | 10.19K | 10.19K | 10.19K | 10.19K | 10.19K | 10.19K | 10.19K | 10.19K | — |
| LEE DANNER & BASS INC | — | — | — | — | — | — | — | — | 50.00K | 50.00K | — | 50.00K | 50.00K |
| Wealth Preservation Advisors, LLC | — | — | 52.60K | 52.60K | 52.60K | 52.00K | 52.00K | — | — | — | — | — | — |
| LBMC INVESTMENT ADVISORS, LLC | — | — | — | — | 20.00K | 20.00K | 20.00K | 20.00K | 20.00K | 22.00K | 22.00K | 22.00K | 22.00K |
| ACADEMY CAPITAL MANAGEMENT | — | — | — | — | — | — | — | — | — | — | — | 20.00K | 20.00K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold PVCT?
As of 2026-Q2, 3 institutional funds reported holding PVCT (PROVECTUS PHARMACEUTICAL INCORPORATED) in SEC 13F filings, with a combined reported value of $8.97K.
How many shares of PVCT do institutions own?
13F filers reported 129.81K shares of PVCT, worth $8.97K in aggregate at the end of 2026-Q2.
Is institutional ownership of PVCT rising or falling?
Share counts moved +0.0% versus the prior quarter — accumulation.
Who are the top institutional holders of PVCT?
The largest 13F holders are HOME FEDERAL BANK OF TENNESSEE, LEE DANNER & BASS INC, Wealth Preservation Advisors, LLC, ACADEMY CAPITAL MANAGEMENT, LBMC INVESTMENT ADVISORS, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of PROVECTUS PHARMACEUTICAL INCORPORATED?
The major shareholders of PROVECTUS PHARMACEUTICAL INCORPORATED (PVCT) by reported 13F value are HOME FEDERAL BANK OF TENNESSEE, LEE DANNER & BASS INC, Wealth Preservation Advisors, LLC, ACADEMY CAPITAL MANAGEMENT, LBMC INVESTMENT ADVISORS, LLC, among 7 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.